Aggregated
33% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Jones Trading
A Jones Trading analyst with 22 tracked ratings across 17 distinct tickers has a 33.3% success rate on the captured sample, focusing on the sources covered.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| SION | 2026-04-28 | buy | $63.00 | Aggregated |
| SYRE | 2026-04-17 | buy | $95.00 | Aggregated |
| HYFT | 2026-04-16 | buy | $5.00 | Aggregated |
| ABCL | 2026-04-10 | buy | $11.00 | Aggregated |
| TRVI | 2026-03-19 | buy | $24.00 | Aggregated |
| NTLA | 2026-03-04 | buy | $29.00 | Aggregated |
| SYRE | 2025-12-01 | buy | $64.00 | Aggregated |
| NTLA | 2025-11-11 | hold | - | Aggregated |
| SION | 2025-09-08 | buy | $46.00 | Aggregated |
| TBPH | 2025-06-17 | buy | $24.00 | Aggregated |
| TBPHTHERAVANCE BIOPHARMA INC | 2025-06-17 | unknown | $24.00 | Aggregated |
| SGMT | 2025-06-06 | buy | $27.00 | Aggregated |
| TVRD | 2025-04-28 | buy | $39.00 | Aggregated |
| TVRDTVARDI THERAPEUTICS, INC. COMMON STOCK | 2025-04-28 | unknown | $39.00 | Aggregated |
| KALV | 2025-03-26 | buy | $30.00 | Aggregated |
| KALVKALVISTA PHARMACEUTICALS INC | 2025-03-26 | unknown | $30.00 | Aggregated |
| CTNM | 2025-03-13 | buy | $23.00 | Aggregated |
| SGMT | 2025-01-27 | buy | $42.00 | Aggregated |
| SYRE | 2024-12-11 | hold | - | Aggregated |
| PHVS | 2024-09-19 | buy | $46.00 | Aggregated |
| PHVSPHARVARIS NV | 2024-09-19 | unknown | $46.00 | Aggregated |
| NTLAINTELLIA THERAPEUTICS INC | 2024-09-17 | unknown | $41.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| SION | 2 | 2026-04-28 | Aggregated |
| SYRE | 3 | 2026-04-17 | Aggregated |
| HYFT | 1 | 2026-04-16 | Aggregated |
| ABCL | 1 | 2026-04-10 | Aggregated |
| TRVI | 1 | 2026-03-19 | Aggregated |
| NTLA | 2 | 2026-03-04 | Aggregated |
| TBPH | 1 | 2025-06-17 | Aggregated |
| TBPHTHERAVANCE BIOPHARMA INC | 1 | 2025-06-17 | Aggregated |
| SGMT | 2 | 2025-06-06 | Aggregated |
| TVRD | 1 | 2025-04-28 | Aggregated |
| TVRDTVARDI THERAPEUTICS, INC. COMMON STOCK | 1 | 2025-04-28 | Aggregated |
| KALV | 1 | 2025-03-26 | Aggregated |
| KALVKALVISTA PHARMACEUTICALS INC | 1 | 2025-03-26 | Aggregated |
| CTNM | 1 | 2025-03-13 | Aggregated |
| PHVS | 1 | 2024-09-19 | Aggregated |
| PHVSPHARVARIS NV | 1 | 2024-09-19 | Aggregated |
| NTLAINTELLIA THERAPEUTICS INC | 1 | 2024-09-17 | Aggregated |